Clinical efficacy was assessed based on skin lesion scores and histological analysis of infected skin sections in a guinea pig model. The results all indicated significant clinical efficacy of COS against T. rubrum dermatophytic infection. COS have excellent potential in future design and development of novel anti-dermatophytic drugs.